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Background: Advanced analytic methods for synthesizing evidence about complex 
interventions continue to be developed. In this paper, we emphasize that the specific research 
question posed in the review should be used as a guide for choosing the appropriate analytic 
method. 
 
Rationale: We present advanced analytic approaches that address four common questions that 
guide reviews of complex interventions: 1) How effective is the intervention?; 2) For whom does 
the intervention work and in what contexts?; 3) What happens when the intervention is 
implemented?; and 4) What decisions are possible given the results of the synthesis? 
 
Discussion: The analytic approaches presented in this paper are particularly useful when each 
primary study differs in components, mechanisms of action, context, implementation, timing, 



















This is the fifth of a seven-part series of papers providing tools and approaches for conducting 
reviews of complex interventions. This paper presents advanced analytic methods that can be 
applied to systematic reviews of complex interventio s.  
 
This paper seeks to update earlier work1-3 with an overview of analytic methods that can address 
synthesis questions involving complex interventions. Reviews of complex interventions (defined 
by Guise et al.4 below) where complexity is considered important frequently seek to address 
several questions within a single review about the int rvention and the health system within 
which it is implemented.  
 
Definition of Complex Interventions4 
All complex interventions have two common characteris ics; they have multiple components 
(intervention complexity) and complicated/multiple causal pathways, feedback loops, synergies, and/or 
mediators and moderators of effect (pathway complexity). Additionally they may also have one or more 
of the following three additional characteristics; target multiple participants, groups, or organizational 
levels (population complexity); require multifaceted adoption, uptake, or integration strategies 
(implementation complexity); or work in a dynamic multi-dimensional environment (contextual 
complexity). 
 
As described in the fourth paper in this series by Viswanathan et al.5 decisions about how to 
conduct a review of a complex intervention depend o a number of factors such as the nature and 
extent of the existing evidence and the resources available for the review. 
 
In this paper, we emphasize the nature of the decision or, in other words, the specific research 
question posed in the review as a guide to the appropriate analytic method to address that 
question. We focus on methods that address four broad questions about complex interventions: a) 
How effective is the intervention?; b) For whom is the intervention effective and in what 
contexts?; c) What happens when the complex intervention is implemented?; and d) What 
decisions are possible given the results of the synthesis? Given space limitations, the discussion 
will introduce analytic methods that can address the e questions about complex interventions, 
and provide pointers to resources for interested rea ers to gain expertise. Table 1 provides a 
summary of the types of questions asked about complex interventions and analytic strategies 
used to support these questions. The analytic techniques discussed here are not unique to reviews 
of complex interventions. They do, however, address the most common questions for reviews 
concerned with complexity. 
 
Table 1. Analytic strategies for complex interventions 
Complex Intervention Question Analytic Strategies 
How effective is the intervention? Single outcomes 
• Random and fixed effects estimates of average 
effect6 
• Network meta-analysis7,8 

















• Multivariate meta-analysis, using methods such as 
multi-level modeling10,11 
• Robust variance estimation12 
For whom is the intervention 




• Frequentist13  
• Bayesian14 
Finite mixture models (structural equation models or latent 
class models)15-17 
Qualitative Comparative Analysis18-21 
What happens when the complex 
intervention is implemented? 
Choice of a wide range of designs, methodologies and 
methods of evidence synthesis 
What decisions are possible given 
the results of the synthesis? 
Decision analysis22 
 
How effective is the intervention? 
 
Systematic reviews of complex interventions may start with a relatively simple question that 
does not necessarily explore complexity: does the intervention, in general, work? Although each 
example of the intervention may differ from others in components, mechanism of action, context, 
implementation or other major domains, policy makers may still be interested in whether the 
complex intervention works better than, say, usual care. Methods for assessing the overall 
effectiveness of an intervention are well-established in the literature, and are covered in detail 
elsewhere.6 We note, however, that new analytic approaches continue to be developed to address 
questions focused on the overall effectiveness of an intervention, or the comparative 
effectiveness of interventions, for example, network meta-analysis,7,8 and single-case designs.9,10 
Some interventions are so complex (such as slum upgrading, see Turley, 201322) that multiple 
effects and impacts are determined at different levels of the health system to provide a suite of 
different options to consider.  
 
When studies of complex interventions examine multiple outcomes, methods such as 
multivariate meta-analysis11 can be used to examine the average effect for a number of 
dependent outcomes. Another alternative is to use weighted least-squares estimates of average 
effect sizes with robust estimation for standard erors12 when studies collect multiple outcomes 
on the same sample.  
 
No matter what analytic strategy is used to examine the average effect of a complex intervention, 
full reporting of results is particularly important. Studies of complex interventions typically 
collect a range of outcomes, both beneficial and harmful, at a number of levels of the system. 
Estimates of effect size for all outcomes along with their associated confidence intervals should 
be provided for each analysis conducted. When appropriate, the consistency and heterogeneity of 
these estimates should also be presented. The literatur  on the effects of complex interventions is 
emerging, and thus there may not be a large number of studies to use in a synthesis. Reporting on 
all the results helps inform the design of future studies on the intervention. 
 
 

















More often, we are focused on the question of whether the effectiveness of the intervention 
varies due to differences among studies in their context, participant samples, or elements of the 
intervention actually implemented. This question ceters on the heterogeneity of the 
intervention’s effects. Given the nature of a complex intervention, we expect that treatment 
effects and impacts will vary due to reasons related to the complexity of the intervention itself. 
There are a number of methods that a reviewer could use to examine how treatment effects from 
a complex intervention vary across studies. Here we will present two general statistical modeling 





Meta-regression is a commonly used technique in meta-analysis,13 and can prove useful in 
exploring heterogeneity in the context of complex interventions. Reviewers should begin with an 
a priori theory about how the effectiveness of a complex intervention may vary as a function of 
intervention components, the context, the implementation of the intervention, the participants, 
the caregivers and so on. A priori theory guards against capitalizing on chance and issues of 
multiplicity which are serious problems in meta-analysis.23 Reviewers then test a model using 
study and intervention characteristics as predictors f r variation in effect size.  
 
Reviewers can take either a frequentist or Bayesian approach to fitting a meta-regression model. 
In frequentist meta-analytic models, the effect size  we observe are assumed to come from a 
process of sampling from a distribution of effect size . Parameters are estimated only from our 
sample at hand. In contrast, Bayesian methods for meta-analysis14 represent a different 
philosophical approach to statistical inference. Specifically, Bayesian inference applies Bayes’ 
theorem to a fully-specified probability model, and the model includes two primary components: 
(1) choosing prior distributions for each unknown parameter such that i  describes the 
uncertainty before the analysis, and (2) choosing appropriate sampling distribution to describe 
the data. Bayes’ theorem then combines the prior dist ibutions of the parameters with the 
sampling distributions of the data to yield posterior distributions of the model parameters. Thus, 
we use evidence from the data to update what is known about our parameters, summarizing the 
new information state using probability distributions. Bayesian analysis can incorporate prior 
knowledge about a complex intervention such as the likely extent of between-study variation that 
we might have from other sources.  
 
Finite mixture modeling 
 
While meta-regression under either a frequentist or Bayesian model is best used when the 
researcher has an a priori model for heterogeneity, finite mixture modeling takes a more 
exploratory approach. Reviewers may find that not all of the relevant, observable characteristics 
are reported in studies, and much unexplained heterogeneity remains. A researcher might wish to 
explore whether there are distinct groupings of intervention effects using finite mixture 

















Finite mixture modeling, also known as latent class modeling, falls within the structural equation 
modeling framework. When researchers apply a finite mixture model to the analysis of effect 
sizes, they assume that there are distinct, latent classes or sub-populations of effect sizes.16 The 
researcher pre-specifies the number of sub-populations of effect sizes that need to be extracted, 
and then uses the results to make sense of the extracted latent classes.17 For example, a 
researcher may find that effect sizes measuring the effectiveness of a complex intervention are 
heterogeneous. Using finite mixture modeling, the researcher finds that effect sizes cluster into 
two classes, and this grouping of effect sizes into two classes accounts for much of the 
heterogeneity. The researcher’s next task is to examine potential reasons for the clustering of the 
effect sizes into two groups to arrive at hypotheses for the observed heterogeneity. Perhaps the 
studies in one cluster all include much younger and healthier patients than those in the second 
cluster.  
 
Finite mixture modeling offers a flexible framework for meta-analytic data analyses. It is 
possible to accommodate missing data and model random effects while testing meta-analytic 
mixture models (including intervention effects on univariate or multivariate outcomes as well as 
moderator analyses) all within the single framework.16 Most user-friendly structural equation 
modeling software programs (including, for example, th  frequently used Mplus software) allow 
testing and estimation of finite mixture models and of more typical meta-analytic research 
hypotheses.  
 
Meta-regression and finite mixture modeling are twomethods used to explore heterogeneity of 
effect sizes in the synthesis of complex interventions. Another method under development for 
exploring heterogeneity is Qualitative Comparative Analysis.18,19 Used within a systematic 
review context, each individual study within the review represents a case, and qualitative 
comparative analysis is used to identify the combinatio s of intervention components, 
implementation features, or contextual characteristics (e.g., population, setting, etc.) that are 
associated with effectiveness of an intervention, or alternatively, ineffectiveness. Because 
qualitative comparative analysis is a relatively new t chnique, and few examples exist, specific 
standards for using the approach, conducting the analysis, and reporting results are in 
evolution.20,21  
 
The use of any analytic method described above has limitations in the synthesis of complex 
interventions. One issue involves the interpretation of the results from these strategies. Models 
examining effect size heterogeneity can only suggest associations among characteristics of 
studies and variation in effect sizes. Causal inferences about how or why effect sizes vary cannot 
be supported by the use of these models. In addition, Berlin et al.24 and Schmid et al.25 warn 
about the potential of aggregation bias when interpreting meta-regression, and, by extension, 
finite mixture modeling results. Relationships that old at the study level may not apply to how 
the intervention operates at the level of the individual patient, and interpretation of meta-
regression should be restricted to the study level. Careful use of these models can help 
researchers explore the potential reasons for heterogeneity in treatment effectiveness, but may 
have limited use with small numbers of studies of complex interventions coupled with many 

















When examining heterogeneity in complex interventions, results from all analyses should be 
reported, particularly any sensitivity or sub-group analyses. This information is particularly 
important in the synthesis of complex interventions as there are likely many different outcomes 
and sub-groups to examine. Given the number of decisions about the number and types of 
analyses conducted, full and transparent reporting helps inform future syntheses and primary 
studies on the complex intervention. 
 
What happens when the complex intervention is implemented? 
 
For many complex interventions where heterogeneity makes it difficult to undertake any 
meaningful synthesis of intervention effects, the more important question is what happens when 
the complex intervention is implemented.26 Understanding the intended and unintended impacts 
of complex interventions in different contexts can provide vital information to inform decision-
making. Evidence to address questions about ‘what happens’ is typically qualitative, quantitative 
or mixed-method (such as interviews, focus groups, stakeholder surveys, etc.). In addition, 
Turley et al.22 suggest that synthesizing other types of quantitative studies (e.g., controlled post 
intervention and uncontrolled before and after studies) not usually included in traditional reviews 
can help understand the wider impacts of interventions such as the association between 
interventions and outcomes. Guidance is available to support reviewers in designing reviews to 
address ‘what happens’ questions. Noyes et al.26 have produced guidance on choice of social 
theory to systematize review processes and inform interpretation of evidence. The UK Medical 
Research Council27 has recently produced detailed guidance on designing theory-informed 
process evaluations to explore implementation, stakeholder experiences and impacts. The 
Medical Research Council’s process evaluation guidance provides a clear framework of the types 
of social theories that may be helpful and the types of evidence that can be synthesized to better 
understand what happens when a complex intervention is implemented. One emerging strategy is 
the synthesis of trial sibling studies. Trial sibling studies are studies of the implementation of an 
intervention that are linked with a randomized contr lled trial. If trial sibling studies are not 
available, Cochrane guidance recommends searching for and synthesizing qualitative studies of 
similar interventions in similar contexts unrelated o the included trials.28  
 
The Cochrane Qualitative and Implementation Methods group provides guidance and 
signposting to appropriate searching, appraisal and sy thesis methods to address ‘what happens’ 
questions.30 There are numerous methodologies and methods from which to select an approach to 
address specific types of ‘what happens’ questions; far too many to summarize here. The 
forthcoming update of the Cochrane Handbook contains  ew chapter on methods for complex 
intervention synthesis. The key issue for review authors to consider when selecting an 
appropriate design, methodology and method(s) is the ‘fit’ with the review questions and the 
type and quality of available evidence as discussed in Viswanathan et al. in this series.5 The ‘fit’ 
of review questions with review design and methodolgy may not become apparent until the 
pool of evidence is known and understood. Reviews of different types of evidence may be 
undertaken separately and then combined in an overarching synthesis, or integrated within a 
single review process. Table 2 outlines various approaches and examples for integrating 

















High quality methodological exemplars exploring ‘what appens when complex interventions 
are implemented’ are increasingly available; see for example, the Cochrane qualitative evidence 
synthesis of the barriers and facilitators to implementation of lay health worker programs29,30 that 
is then integrated with the corresponding effectiveness review using a logic model.  
 
Table 2: Qualitative and quantitative evidence integration approaches.  
Integrative Approach Definition and citations for examples 
1. Qualitative Comparative 
Analysis 
Quantification of qualitative evidence in a single 
review20,21 
2. Bayesian Synthesis Quantification of qualitative e idence in a single review33 
3. Oliver’s Framework for the 
synthesis of qualitative and 
quantitative evidence 
Creating matrices to juxtapose quantitative and qualitative 
evidence in original form31 
4. Logic Models Developing explanatory lines of logic to integrate evidence 
of effect with qualitative synthesized hypotheses 
5. Thematic synthesis Qualitisizing quantitative findings 
6. Realist Review, Critical 
Interpretive Synthesis, Meta-
study/Meta-Summary 
Uses data in its original form32-34 
 
7. Narrative Synthesis Guidance Provides a theory-informed framework for the synthesis of 
quantitative and qualitative evidence that draws on a tool 
box approach from the above methods35 
 
What decisions are possible given the results of the synthesis? 
 
Often researchers undertake a review of a complex int rvention in order to make a decision or 
take an action. In the context of evidence synthesis to nform decision making about clinical or 
public health interventions, “decision analysis” typically refers to the use of mathematical 
computer models to estimate the probability of specific outcomes of interest of two or more 
competing interventions. Based on the probabilities of these outcomes and the implicit or explicit 
value that the decision maker places on each outcome, the optimal decision can be identified if 
there is consensus on the definition of “optimal”. In the setting of decisions where the cost of the 
interventions are considered, this can be formally defined as the decision maker’s “willingness to 
pay” for a given level of health benefit.36 In settings where costs are not considered, estimates of 
the expected number of harms and benefits with eachoption can be used, although there has 
been much less consideration of the definition of an acceptable “harm/benefit” ratio.37  
 
The real power of the method lies in the ability to quantify the effect of uncertainty in the 
underlying probability estimates that are included in the model—clinical effectiveness, 
probability of adverse events, costs of specific outc mes.36 Although decision modeling can be 
used in the evaluation of simple interventions, such a framework is especially powerful in the 
evaluation of complex interventions where the available interventions may not be studied in a 
single study, or where specific combinations of interventions may not ethically be examined by a 
RCT. A decision model allows the user to bring togeher evidence from diverse sources, to 
explore novel combinations of interventions, and to evaluate the gaps in the evidence and needs 
















parameters, either across a range defined by the literature or expert opinion, or stochastically 
using distributions obtained from the available evid nce), the impact of uncertainty in 
probabilities can be illustrated, and the relative contributions of specific aspects of uncertainty 
can be identified.22 This, in turn, can be very useful for identifying future research needs.38-40 The 
method can still be useful even if no direct estimaes of a parameter are available. For example, 
in the setting of a complex intervention where there is uncertainty about uptake among patients 
outside of a trial setting, the proportion of the population accepting the intervention, as well as 
the potential impact of additional components of the intervention on acceptability, can be varied 
to illustrate the impact of acceptability on overall health outcomes.39  
 
This flexibility also allows the model to predict outcomes under different scenarios. For 
example, if there is evidence of differential effectiveness in specific subgroups, this can be 
modeled by changing the relevant parameters. Subgrop-specific outcome probabilities can be 
combined to estimate the population-level effect under different subgroup distributions. In the 
setting of complex interventions, the effect of differences in specific subgroups can be modeled 




The analytic methods discussed here provide tools fr addressing four of the key questions 
commonly asked about a complex intervention: a) How effective is the intervention?, b) For 
whom is the intervention effective and in what contexts?, c) What happens when the complex 
intervention is implemented?, and d) What decisions are possible given the results of the 
synthesis? The methods discussed here can be used in the synthesis of any intervention, but are 
particularly useful when each primary study of the complex intervention differ in components, 
mechanisms of action, context, implementation and many other domains. Future methodological 
research is needed in developing methods that fit or match the kinds of questions most important 
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